Sale!

Comprehensive Ear Nose Throat Panel NGS Genetic Test

4,400 د.إ

-27%

The Comprehensive Ear Nose Throat (ENT) Panel NGS Genetic Test offered by DNA Labs UAE is a cutting-edge diagnostic tool designed to provide a detailed genetic analysis related to a wide array of ENT conditions. Utilizing Next-Generation Sequencing (NGS) technology, this panel can identify genetic variations and mutations that may contribute to or cause various ENT disorders, including hearing loss, chronic ear infections, sinusitis, and other related conditions.

Priced at 4400 AED, the test is meticulously designed to offer insights into the genetic predisposition of individuals towards ENT ailments, facilitating early detection, personalized treatment plans, and preventive measures. By analyzing a comprehensive set of genes, the test ensures a thorough evaluation, making it a valuable resource for patients experiencing ENT issues, as well as for healthcare providers looking for an in-depth understanding of their patients’ conditions to tailor more effective treatment strategies.

Performed at the state-of-the-art facilities of DNA Labs UAE, the test emphasizes accuracy, reliability, and confidentiality, ensuring that patients receive the highest standard of genetic testing services.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

Comprehensive Ear Nose Throat Panel NGS Genetic Test

Cost: AED 4400.0

Symptoms, Diagnosis, and Test Details

The Comprehensive Ear Nose Throat (ENT) Panel is a Next-Generation Sequencing (NGS) genetic DNA test that analyzes a patient’s DNA for genetic mutations associated with various ENT disorders. This panel is designed to identify mutations that may cause hearing loss, balance disorders, chronic sinusitis, and other related conditions.

The test analyzes a patient’s DNA for mutations in over 150 genes associated with ENT disorders. These genes are involved in various biological processes such as the development and maintenance of the ear, nose, and throat tissues, as well as the regulation of immune responses.

The test is performed using a small blood sample or saliva sample, which is then analyzed using NGS technology. The results of the test are interpreted by a team of genetic counselors and medical professionals, who provide a comprehensive report detailing any identified mutations and their associated risks.

The Comprehensive ENT Panel can be used to diagnose genetic disorders that may be causing a patient’s ENT symptoms, as well as to identify potential carriers of genetic mutations that may be passed on to future generations. This information can help patients and their healthcare providers make informed decisions about their care and treatment options.

Test Name: Comprehensive Ear Nose Throat Panel NGS Genetic DNA Test

Components: Price 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for Comprehensive Ear Nose Throat Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABHD12, ACTB, ACTG1, ADCY1, ADGRV1, AIFM1, ANKH, ATP2B2, ATP6V1B1, ATP6V1B2, BCS1L, BDP1, BSND, BTD, CABP2, CACNA1D, CCDC50, CD151, CD164, CDC14A, CDH23, CDKN1C, CEACAM16, CEP78, CHD7, CHSY1, CIB2, CISD2, CLDN14, CLIC5, CLPP, CLRN1, COCH, COL11A1, COL11A2, COL2A1, COL4A3, COL4A4, COL4A5, COL4A6, COL9A1, COL9A2, COL9A3, CRYM, DCAF17, DCDC2, DIABLO, DIAPH1, DIAPH3, DLX5, DMXL2, DNMT1, DSPP, EDN3, EDNRB, ELMOD3, EPS8, EPS8L2, ESPN, ESRP1, ESRRB, EYA1, EYA4, FDXR, FGF3, FGFR1, FGFR2, FGFR3, FOXI1, GAB1, GATA3, GIPC3, GJA1, GJB2, GJB3, GJB6, GPRASP2, GPSM2, GRHL2, GRXCR1, GRXCR2, GSDME, HARS1, HARS2, HGF, HOMER2, HOXB1, HSD17B4, ILDR1, KARS1, KCNE1, KCNJ10, KCNQ1, KCNQ4, KIT, KITLG, LARS2, LHFPL5, LOXHD1, LRP2, LRTOMT, MAN2B1, MANBA, MARVELD2, MCM2, MET, MGP, MITF, MPZL2, MSRB3, MYH14, MYH9, MYO15A, MYO3A, MYO6, MYO7A, NARS2, NDP, NLRP3, OPA1, OSBPL2, OTOA, OTOF, OTOG, OTOGL, P2RX2, PAX3, PCDH15, PDZD7, PEX1, PEX26, PEX6, PJVK, PMP22, PNPT1, POLR1C, POLR1D, POU3F4, POU4F3, PRPS1, RDX, RMND1, ROR1, RPS6KA3, S1PR2, SALL1, SALL4, SEMA3E, SERPINB6, SIX1, SIX5, SLC12A1, SLC17A8, SLC19A2, SLC26A4, SLC26A5, SLC29A3, SLC33A1, SLC44A4, SLC52A2, SLC52A3, SLITRK6, SMAD4, SMPX, SNAI2, SOX10, SOX2, SPATA5, STRC, SUCLA2, SUCLG1, SYNE4, TBC1D24, TBX1, TCOF1, TECTA, TFAP2A, TIMM8A, TJP2, TMC1, TMIE, TMPRSS3, TNC, TPRN, TRIOBP, TRMU, TSPEAR, TWNK, TYR, USH1C, USH1G, USH2A, VCAN, WBP2, WFS1, WHRN

 

Test NameComprehensive Ear Nose Throat Panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeEar Nose Throat Disorders
DoctorENT Doctor
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Comprehensive Ear Nose Throat Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABHD12, ACTB, ACTG1, ADCY1, ADGRV1, AIFM1, ANKH, ATP2B2, ATP6V1B1, ATP6V1B2, BCS1L, BDP1, BSND, BTD, CABP2, CACNA1D, CCDC50, CD151, CD164, CDC14A, CDH23, CDKN1C, CEACAM16, CEP78, CHD7, CHSY1, CIB2, CISD2, CLDN14, CLIC5, CLPP, CLRN1, COCH, COL11A1, COL11A2, COL2A1, COL4A3, COL4A4, COL4A5, COL4A6, COL9A1, COL9A2, COL9A3, CRYM, DCAF17, DCDC2, DIABLO, DIAPH1, DIAPH3, DLX5, DMXL2, DNMT1, DSPP, EDN3, EDNRB, ELMOD3, EPS8, EPS8L2, ESPN, ESRP1, ESRRB, EYA1, EYA4, FDXR, FGF3, FGFR1, FGFR2, FGFR3, FOXI1, GAB1, GATA3, GIPC3, GJA1, GJB2, GJB3, GJB6, GPRASP2, GPSM2, GRHL2, GRXCR1, GRXCR2, GSDME, HARS1, HARS2, HGF, HOMER2, HOXB1, HSD17B4, ILDR1, KARS1, KCNE1, KCNJ10, KCNQ1, KCNQ4, KIT, KITLG, LARS2, LHFPL5, LOXHD1, LRP2, LRTOMT, MAN2B1, MANBA, MARVELD2, MCM2, MET, MGP, MITF, MPZL2, MSRB3, MYH14, MYH9, MYO15A, MYO3A, MYO6, MYO7A, NARS2, NDP, NLRP3, OPA1, OSBPL2, OTOA, OTOF, OTOG, OTOGL, P2RX2, PAX3, PCDH15, PDZD7, PEX1, PEX26, PEX6, PJVK, PMP22, PNPT1, POLR1C, POLR1D, POU3F4, POU4F3, PRPS1, RDX, RMND1, ROR1, RPS6KA3, S1PR2, SALL1, SALL4, SEMA3E, SERPINB6, SIX1, SIX5, SLC12A1, SLC17A8, SLC19A2, SLC26A4, SLC26A5, SLC29A3, SLC33A1, SLC44A4, SLC52A2, SLC52A3, SLITRK6, SMAD4, SMPX, SNAI2, SOX10, SOX2, SPATA5, STRC, SUCLA2, SUCLG1, SYNE4, TBC1D24, TBX1, TCOF1, TECTA, TFAP2A, TIMM8A, TJP2, TMC1, TMIE, TMPRSS3, TNC, TPRN, TRIOBP, TRMU, TSPEAR, TWNK, TYR, USH1C, USH1G, USH2A, VCAN, WBP2, WFS1, WHRN
Test Details

The Comprehensive Ear Nose Throat (ENT) Panel is a Next-Generation Sequencing (NGS) genetic DNA test that analyzes a patient’s DNA for genetic mutations associated with various ENT disorders. This panel is designed to identify mutations that may cause hearing loss, balance disorders, chronic sinusitis, and other related conditions.

The test analyzes a patient’s DNA for mutations in over 150 genes associated with ENT disorders. These genes are involved in various biological processes such as the development and maintenance of the ear, nose, and throat tissues, as well as the regulation of immune responses.

The test is performed using a small blood sample or saliva sample, which is then analyzed using NGS technology. The results of the test are interpreted by a team of genetic counselors and medical professionals, who provide a comprehensive report detailing any identified mutations and their associated risks.

The Comprehensive ENT Panel can be used to diagnose genetic disorders that may be causing a patient’s ENT symptoms, as well as to identify potential carriers of genetic mutations that may be passed on to future generations. This information can help patients and their healthcare providers make informed decisions about their care and treatment options.